Evidence map›Paper›PMID 28739802›Full record

ArticleThe Journal of biological chemistry2017

TGF-β1 regulates the expression and transcriptional activity of TAZ protein via a Smad3-independent, myocardin-related transcription factor-mediated mechanism.

Maria Zena Miranda, Janne Folke Bialik, Pam Speight, Qinghong Dan, Tony Yeung, Katalin Szászi, Stine F Pedersen, András Kapus

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Repurposing verteporfin and hyaluronic acid gel for ocular surface treatment to prevent corneal scarring.Journal of controlled release : official journal of the Controlled Release Society · 2025
    Article
  11. Article
  12. Review
  13. Targeting Fibrosis in Right Ventricular Pressure Overload: Balancing on a Tightrope?American journal of respiratory cell and molecular biology · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Maria Zena MirandaFrom the Keenan Research Centre for Biomedical Science of the St. Michael's Hospital.
Janne Folke BialikFrom the Keenan Research Centre for Biomedical Science of the St. Michael's Hospital.
Pam SpeightFrom the Keenan Research Centre for Biomedical Science of the St. Michael's Hospital.
Qinghong DanFrom the Keenan Research Centre for Biomedical Science of the St. Michael's Hospital.
Tony YeungFrom the Keenan Research Centre for Biomedical Science of the St. Michael's Hospital.
Katalin SzásziFrom the Keenan Research Centre for Biomedical Science of the St. Michael's Hospital.
Stine F Pedersenthe Department of Cell and Developmental Biology, University of Copenhagen, Copenhagen DK-2100, Denmark.
András KapusFrom the Keenan Research Centre for Biomedical Science of the St. Michael's Hospital, kapusa@smh.ca.
St. Michael's Hospital · CAUniversity of Copenhagen · DKUniversity of Toronto · CA

Funding

CIHR MOP-106625CIHR MOP-130463
6 · The paper itself

Abstract

Hippo pathway transcriptional coactivators TAZ and YAP and the TGF-β1 (TGFβ) effector Smad3 regulate a common set of genes, can physically interact, and exhibit multilevel cross-talk regulating cell fate-determining and fibrogenic pathways. However, a key aspect of this cross-talk, TGFβ-mediated regulation of TAZ or YAP expression, remains uncharacterized. Here, we show that TGFβ induces robust TAZ but not YAP protein expression in both mesenchymal and epithelial cells. TAZ levels, and to a lesser extent YAP levels, also increased during experimental kidney fibrosis. Pharmacological or genetic inhibition of Smad3 did not prevent the TGFβ-induced TAZ up-regulation, indicating that this canonical pathway is dispensable. In contrast, inhibition of p38 MAPK, its downstream effector MK2 (

Indexed as

AcyltransferasesAdaptor Proteins, Signal TransducingAnimalsCell Cycle ProteinsCells, CulturedMicep38 Mitogen-Activated Protein KinasesPhosphoproteinsRNA, MessengerSmad3 ProteinTrans-ActivatorsTranscription FactorsTransforming Growth Factor beta1YAP-Signaling ProteinsAcyltransferasesAdaptor Proteins, Signal TransducingCell Cycle ProteinsMrtfa protein, mousep38 Mitogen-Activated Protein KinasesPhosphoproteinsRNA, MessengerSmad3 ProteinSmad3 protein, mousetafazzin protein, mouseTrans-ActivatorsTranscription FactorsTransforming Growth Factor beta1Yap1 protein, mouseYAP-Signaling Proteinsfibrosiskidneymyocardin-related transcription factorp38 MAPKSMAD transcription factorTAZtransforming growth factor beta (TGF-B)

Identifiers

PMID28739802
PMCPMC5592669
OpenAlexW2737033892

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.